Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Capecitabine with Radiation for Resectable Gastric Cancer
NCT00335959Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- May 2006
- Primary completion
- Apr 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, oxaliplatin in gastric adenocarcinoma, sponsored by SWOG Cancer Research Network. Started May 2006; status: terminated.
02
Drugs
capecitabineoxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00335959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335959.